Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency.
about
Meat Science and Muscle Biology Symposium: stem cell niche and postnatal muscle growthThe Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaDlk1 is necessary for proper skeletal muscle development and regeneration.Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method.Delta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration.Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine.DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.Adrenocortical stem and progenitor cells: implications for adrenocortical carcinomaHepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.Morphogens and hepatic stellate cell fate regulation in chronic liver disease.Induction of hepatocellular carcinoma by in vivo gene targeting.Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.Gene expression profiling of breast cancer in Lebanese women.Prognostic values of DLK1 for surgery and imatinib mesylate adjuvant therapy in gastrointestinal stromal tumors.Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity.Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiationLiver stem/progenitor cells: their characteristics and regulatory mechanisms.International pediatric liver cancer pathological classification: current trend.DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.Morphogen-related therapeutic targets for liver fibrosis.A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.Rho/ROCK-dependent inhibition of 3T3-L1 adipogenesis by G-protein-deamidating dermonecrotic toxins: differential regulation of Notch1, Pref1/Dlk1, and β-catenin signaling.Prenatal notch1 receptor blockade by protein delta homolog 1 (DLK1) modulates adipocyte size in vivo.IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.Isolation and Expansion of Hepatic Stem-like Cells from a Healthy Rat Liver and their Efficient Hepatic Differentiation of under Well-defined Vivo Hepatic like Microenvironment in a Multiwell Bioreactor.Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.Reduced salivary gland size and increased presence of epithelial progenitor cells in DLK1-deficient mice.Hepatic stem cells with self-renewal and liver repopulation potential are harbored in CDCP1-positive subpopulations of human fetal liver cells.A Monoclonal Antibody to Human DLK1 Reveals Differential Expression in Cancer and Absence in Healthy Tissues
P2860
Q26824418-F1BBA966-9FE8-4D3D-8C83-E728555C0CE0Q28071619-0D9C16DD-1E32-4CCD-9DEE-0BB0150468DFQ33760580-F0931A48-F7C5-4F1E-AF43-B8D726E9E614Q34256683-5C6B6197-9F4A-45B4-A379-3E637AD571DBQ34663937-8EBC9836-DC27-4963-9C1D-DCBDC5E18E53Q34964650-9CFC1884-BB5A-413E-9784-4F6BE3678674Q35624893-6CF8AA80-6E67-4A34-B147-ADC2C38F6614Q35782788-C523A4EF-CE00-4630-A51D-02E38AAA37D5Q35880000-90EB3D6C-6441-48A5-B557-335F821861E1Q35914173-5C7EB2F4-380D-4E87-AF0B-710DBCBBAC27Q36094151-6862A9CE-541A-497A-8061-94D42872670FQ36190702-58E008B4-AA67-4BCE-9295-6FCA8D96226FQ36387183-044910D0-D16B-43C6-97D5-F99A76FF9B1DQ37421684-F80AE3C2-98AC-4740-B00F-BEE415896F1FQ37447959-014E24AA-79AA-4E04-ADD4-0BE692DD8088Q37625410-C72626E7-D19D-433D-A8A5-9E7292D0EFEFQ37687639-88C3EC1A-4793-43D1-81F0-8F23276AEBFDQ37827017-E8BC550D-E05D-430A-A760-AAF8B5CD93E7Q38153612-330ED1C4-EE20-4F74-A420-B3D762632950Q38237444-86ED16DB-306A-4321-B3DE-6D32E42B109BQ38553312-FF675C0A-E2BC-43C1-AE96-3FC93512873EQ38917207-0FF9C29C-D10E-4080-8E3F-A1CA7BD1575FQ39291656-71C212D2-F4E6-49FC-8032-FE49571BDE78Q40395028-B9FE464A-9F9E-47A9-A690-9BE5AFC4DC6DQ40478066-B4B789D6-2937-49D9-BE24-ED175BF2F33BQ40895976-BF93632B-BC39-4B33-A155-08666F9C2B67Q41421588-2190205B-B477-4939-8A51-71695B5BFF17Q46405678-B7A7C8C6-DAD7-48A0-B298-9CB851C987A5Q47337053-D763AEF1-9D30-42AF-9EEB-63E42709E0B5Q48103674-565AFBC5-049F-4471-985B-131816DF2DD4Q57911915-B2B998CC-5E2D-4C73-B341-3A015E786645
P2860
Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@en
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@nl
type
label
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@en
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@nl
prefLabel
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@en
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@nl
P2093
P2860
P356
P1476
Dlk-1, a cell surface antigen ...... arcinomas at a high frequency.
@en
P2093
Akira Kamei
Atsushi Miyajima
Eiji Shinozaki
Hiroyuki Yanai
Kiyohiko Hatake
Koji Nakamura
Nobuyuki Mizunuma
Susumu Hijioka
Takaaki Ikari
Yuichi Ishikawa
P2860
P356
10.1093/JB/MVQ034
P577
2010-03-30T00:00:00Z